期刊论文861-P: Targeting Activin Type II Receptors—Develop Monoclonal Antibodies LAE102, LAE103, and LAE123 as Candidate Therapeutics for Muscle Growth and Fat Reduction复制

DOI: 10.2337/db25-861-p复制

文献链接: https://diabetesjournals.org/diabetes/article/74/Supplement_1/861-P/158313/861-P-Targeting-Activin-Type-II-Receptors-Develop复制

其他信息:

出版社: American Diabetes Association
作者: RUIPENG ZHANG; MENGXUE YANG; JUSTIN XIANGJU GU; MEIJUAN HU; JUNYAN CHEN; WANG A. LI; LIN XIAOFEN; XIAOYUE ZHANG; CHRIS LU
全文下载地址: https://diabetesjournals.org/diabetes/article/74/Supplement_1/861-P/158313/861-P-Targeting-Activin-Type-II-Receptors-Develop